Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jürgen K. Rockstroh"'
Autor:
Ninon Taylor, Martin Obermeier, Dirk Berzow, Saleta Sierra, Jean Ruelle, Matthias Döring, Ricardo Jorge Camacho, Björn Jensen, Annemarie M. J. Wensing, Charlotte Charpentier, Josef Eberle, Kamal Mansinho, Rolf Kaiser, Jürgen K. Rockstroh, Perpétua Gomes, Diane Descamps, Lutz G Prof Dr Guertler, Martin Stürmer
Publikováno v:
Clinical infectious diseases, Vol. 72, no. 3, p. 503-509 (2021)
Human immunodeficiency virus–2 (HIV-2) is endemic in some countries in West Africa. Due to the lower prevalence in industrialized countries, there is limited experience and knowledge on the management of individuals living with HIV-2 in Europe. Com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c198cbd576fa902bcd5d94411a0c79
https://hdl.handle.net/2078.1/243908
https://hdl.handle.net/2078.1/243908
Autor:
Katharine E A Darling, Dominique L Braun, Adriano Lazzarin, Elżbieta Jabłonowska, Mathieu Rougemont, Lars Iversen Gjærde, Manuel Battegay, Lars Peters, Valérie Martel-Laferrière, Jürgen K. Rockstroh, Leah Shepherd, Andri Rauch, John Gill, Amanda Mocroft, Marina B. Klein, Jens D Lundgren
Publikováno v:
Gjærde, Lars I; Shepherd, Leah; Jablonowska, Elzbieta; Lazzarin, Adriano; Rougemont, Mathieu; Darling, Katharine; Battegay, Manuel; Braun, Dominique; Martel-Laferriere, Valerie; Lundgren, Jens D; Rockstroh, Jürgen K; Gill, John; Rauch, Andri; Mocroft, Amanda; Klein, Marina B; Peters, Lars (2016). Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study. Clinical infectious diseases, 63(6), ciw380. Oxford University Press 10.1093/cid/ciw380
BACKGROUND While liver-related deaths in HIV and hepatitis C virus (HCV) co-infected individuals have declined over the last decade, hepatocellular carcinoma (HCC) may have increased. We described the epidemiology of HCC and other liver events in a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8621de5930e8afc840b7d30d973d4f70
https://europepmc.org/articles/PMC4996136/
https://europepmc.org/articles/PMC4996136/
Autor:
Catherine Creticos, Gordon Crofoot, Erin Quirk, Ya-Pei Liu, Hal Martin, Edwin DeJesus, Peter Ruane, Godson Oguchi, Jürgen K. Rockstroh, Jean-Michel Molina, Hiba Graham, Andrew T. A. Cheng, Ellen Koenig, Kristen Andreatta, Eric S. Daar
Publikováno v:
Open Forum Infectious Diseases
Background Boosted protease inhibitor regimens (bPIs) are effective and often used in HIV-infected individuals with difficulties with adherence, but they can have drug–drug interactions and GI adverse effects. Bictegravir (B), a novel, potent integ
Autor:
Berit A. Payer, Martin Vogel, Mark Nelson, Axel Baumgarten, Jan-Christian Wasmuth, Jürgen K. Rockstroh, Carolynne Schwarze-Zander, Emma Page, Stefan Mauss, Christoph Boesecke
To the Editor—We are thankful for the comments made by Fierer et al, which enrich the current discussion on the natural course of acute hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)–infected individuals [1]. However, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1100d7555d56d1ad7f2e45b270ff3e7e
https://europepmc.org/articles/PMC3697434/
https://europepmc.org/articles/PMC3697434/